Table 3.
Long-term prescription of antidepressants and anticonvulsants in patients with incident OA
| Age | Amitriptyline | Nortriptyline | Duloxetine | Gabapentin | Pregabalin | |
|---|---|---|---|---|---|---|
| N (% users/% population) | N (% users/% population) | N (% users/% population) | N (% users/% population) | N (% users/% population) | ||
| Female | 30–49 | 98 (44.1/2.9) | 10 (41.7/0.3) | 20 (64.5/1.9) | 11 (33.3/0.3) | 41 (38.0/1.2) |
| 50–69 | 392 (41.7/2.5) | 61 (46.2/0.4) | 66 (53.7/0.3) | 72 (34.0/0.5) | 233 (37.4/1.5) | |
| 70+ | 246 (40.7/2.4) | 67 (49.6/0.7) | 24 (36.9/0.4) | 52 (34.2/0.5) | 142 (36.1/1.4) | |
| Male | 30–49 | 29 (37.6/1.4) | 8 (47.1/0.4) | 6 (46.2/2.3) | 3 (11.1/0.1) | 17 (27.4/0.8) |
| 50–69 | 140 (40.2/1.5) | 25 (38.5/0.3) | 19 (45.2/0.5) | 31 (28.4/0.3) | 111 (40.1/1.2) | |
| 70+ | 71 (42.3/1.5) | 12 (32.4/0.2) | 4 (20.0/0.4) | 10 (21.3/0.2) | 59 (37.6/1.2) |